Insider trades

Kory James Wentworth, CFO of Entrada Therapeutics TRDA, has filed 0 purchases and 24 sales on the open market. Over the past 12 months that comes to a net sale of $433.6K. The latest trade was on 04/01.

Kory James Wentworth

CFO
First filing
23/03/03
Trades
74 trades
Buys / sales
0 / 24
12-month net buying
−$433.6K
Last trade
04/01

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan04/0104/022,500 sh$12.95$32,375−2.1%
TRDA
Open-market sale10b5-1 plan03/09–03/1003/1116,477 sh2 trades$13.01avg.$214,428.76−11.9%
Open-market sale10b5-1 plan03/0403/067,988 sh$12.25$97,853−5.5%
Open-market sale10b5-1 plan25/11/2125/11/248,910 sh$9.98$88,921.8−7.5%
Open-market sale10b5-1 plan25/03/1725/03/191,784 sh$10.67$19,035.28−1.6%
TRDA
Open-market sale10b5-1 plan24/11/29–24/12/0224/12/036,000 sh2 trades$20.00avg.$119,970−7.5%
Open-market sale10b5-1 plan24/11/1124/11/138,637 sh$19.98$172,567.26−10.5%
Open-market sale10b5-1 plan24/09/0924/09/103,195 sh$14.97$47,829.15−4.0%
Open-market sale10b5-1 plan24/07/0824/07/101,758 sh$14.95$26,282.1−2.1%
Open-market sale10b5-1 plan24/03/0624/03/084,086 sh$12.31$50,298.66−5.2%
TRDA
Open-market sale10b5-1 plan23/12/21–23/12/2623/12/2612,500 sh4 trades$15.59avg.$194,819.9−20.1%
TRDA
Open-market sale10b5-1 plan23/09/0623/09/06950 sh2 trades$13.48avg.$12,804.18−1.9%
TRDA
Open-market sale10b5-1 plan23/07/10–23/07/1123/07/1210,000 sh2 trades$17.99avg.$179,877.68−21.4%
TRDA
Open-market sale10b5-1 plan23/06/2123/06/2317,500 sh2 trades$15.01avg.$262,639.31−38.5%
TRDA
Open-market sale23/03/0223/03/031,747 sh2 trades$10.52avg.$18,385.27−4.0%